« Schering-Plough Announces FDA Approval of NOXAFIL(R) for Treatment of Oropharyngeal Candidiasis
Colorado drug maker takes hit »

FDA Approves New Treatment for Allergies

Published by FDA - Topix.net October 23rd, 2006 in Uncategorized

The Food and Drug Administration announced today the approval of Omnaris nasal spray, a new drug for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis, commonly known as …
Comment

« Phase 3 Trial of Lubiprostone Demonstrates Relief of Symptoms…
Drug stocks dip; Forest, Replidyne slide on FDA decision (Market Watch) »

FDA Approves New Treatment for Allergies

Published by Food and Drug Administration October 23rd, 2006 in Regulatory Affairs

FDA announced today the approval of Omnaris (ciclesonide) nasal spray, a new drug for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis, commonly known as hay fever, in adults and children 12 years of age and older.

Search